MHLW (Japan) approves Lunsumio (mosunetuzumab) to treat r/r follicular lymphoma – Chugai Pharma
Chugai Pharmaceutical Co., Ltd. announced that it has obtained regulatory approval from the Ministry of Health, Labour and Welfare (MHLW) for Lunsumio for intravenous infusion 1mg” and “Lunsumio… read more.
